Saturday, May 16, 2015

AACE: Saroglitazar Safe, Effective in 9-Month Study

(MedPage Today) -- Dual-acting saroglitazar effective for dyslipidemia and hyperglycemia with few side effects.
Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)